WallStSmart

Viant Technology Inc (DSP)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Viant Technology Inc generates 33% more annual revenue ($344.20M vs $258.90M). DSP leads profitability with a 2.4% profit margin vs -15.5%. DSP earns a higher WallStSmart Score of 62/100 (C+).

DSP

Buy

62

out of 100

Grade: C+

Growth: 9.3Profit: 5.0Value: 7.3Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DSPUndervalued (+75.6%)

Margin of Safety

+75.6%

Fair Value

$40.31

Current Price

$11.38

$28.93 discount

UndervaluedFair: $40.31Overvalued
ZEPPUndervalued (+48.8%)

Margin of Safety

+48.8%

Fair Value

$46.82

Current Price

$17.47

$29.35 discount

UndervaluedFair: $46.82Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DSP4 strengths · Avg: 8.5/10
EPS GrowthGrowth
255.1%10/10

Earnings expanding 255.1% YoY

PEG RatioValuation
0.738/10

Growing faster than its price suggests

Price/BookValuation
2.4x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
22.3%8/10

Revenue surging 22.3% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

DSP3 concerns · Avg: 3.3/10
P/E RatioValuation
30.2x4/10

Premium valuation, high expectations priced in

Market CapQuality
$693.61M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
2.4%3/10

2.4% margin — thin

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : DSP

The strongest argument for DSP centers on EPS Growth, PEG Ratio, Price/Book. Revenue growth of 22.3% demonstrates continued momentum. PEG of 0.73 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : DSP

The primary concerns for DSP are P/E Ratio, Market Cap, Profit Margin. Thin 2.4% margins leave little buffer for downturns.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

DSP profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

DSP scores higher overall (62/100 vs 41/100) and 22.3% revenue growth. ZEPP offers better value entry with a 48.8% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Viant Technology Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Viant Technology Inc. is an adware company. The company is headquartered in Irvine, California.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?